(4-Fluoro-1-methylpiperidin-4-yl)methanamine dihydrochloride

Catalog No.: 
ACLPHK104
CAS No.: 
2306270-97-1
Molecular Formula: 
C7H17Cl2FN2
Molecular Weight: 
219.13
(4-Fluoro-1-methylpiperidin-4-yl)methanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$223.00In stockInquiry
250mg95%$298.00In stockInquiry
500mg95%$496.00In stockInquiry
1g95%$745.00In stockInquiry
5g95%$2237.00InquiryInquiry
10g95%$3731.00InquiryInquiry
25g95%$8207.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-Fluoro-1-methylpiperidin-4-yl)methanamine dihydrochloride
IUPAC Name(4-fluoro-1-methylpiperidin-4-yl)methanamine dihydrochloride
MDL No.MFCD31742721
Molecular FormulaC7H17Cl2FN2
Molecular Weight219.13
SMILESNCC1(F)CCN(C)CC1.[H]Cl.[H]Cl
InChI KeyMTZWAMIYSMNXDE-UHFFFAOYSA-N
Synonym2306270-97-1 | (4-fluoro-1-methyl-4-piperidyl)methanamine dihydrochloride | (4-Fluoro-1-methylpiperidin-4-yl)methanamine dihydrochloride | starbld0044223 | SCHEMBL14311913 | MFCD31742721 | PB42238 | BS-43597 | P20029 | (4-Fluoro-1-methyl-4-piperidyl)metha
CAS No.2306270-97-1
PubChem CID89303196

Synthetic Route by SureRoute

1. ACLPHK104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLPHK104 route product structure diagram
    ACLPHK1042306270-97-1In Stock
Inquiry

2. ACLPHK104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLPHK104 route product structure diagram
    ACLPHK1042306270-97-1In Stock
Inquiry

3. ACLPHK104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLPHK104 route product structure diagram
    ACLPHK1042306270-97-1In Stock
Inquiry

Comments (0)